Plus Therapeutics (PSTV) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free PSTV Stock Alerts $2.16 -0.08 (-3.57%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Plus Therapeutics Stock Price Performance5 Day Performance+7.46%1 Month Performance+15.51%3 Month Performance+9.64%6 Month Performance+54.84%Year-To-Date Performance+23.42%1 Year Performance-54.24% Receive PSTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… PSTV Stock Chart for Saturday, May, 11, 2024 PSTV Chart by TradingView Plus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$2.24$2.16-3.57%$2.24$2.1065,469 shs$9.24 million05/09/2024$2.27$2.24-1.32%$2.37$2.1530,558 shs$9.59 million05/08/2024$2.13$2.27+6.57%$2.48$2.10234,732 shs$9.72 million05/07/2024$2.01$2.13+5.97%$2.19$1.86134,752 shs$9.12 million05/06/2024$1.80$2.01+11.67%$2.08$1.672.13 million shs$8.60 million05/03/2024$1.80$1.80$1.84$1.803,705 shs$7.70 million Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$1.72$1.80+4.65%$1.92$1.7851,597 shs$7.70 million05/01/2024$1.74$1.72-1.18%$1.78$1.715,019 shs$7.36 million04/30/2024$1.66$1.74+4.85%$1.76$1.697,565 shs$7.45 million04/29/2024$1.69$1.66-1.78%$1.72$1.658,716 shs$7.11 million04/26/2024$1.67$1.69+1.50%$1.70$1.6016,331 shs$7.23 million04/25/2024$1.60$1.67+4.06%$1.67$1.525,262 shs$7.12 million04/24/2024$1.63$1.60-1.84%$1.64$1.558,444 shs$6.85 million04/23/2024$1.66$1.63-1.81%$1.68$1.6117,177 shs$6.98 million04/22/2024$1.63$1.66+1.84%$1.75$1.54199,170 shs$7.11 million04/19/2024$1.71$1.64-4.09%$1.77$1.6324,591 shs$7.02 million04/18/2024$1.77$1.71-3.12%$1.79$1.696,766 shs$7.32 million04/17/2024$1.75$1.77+0.86%$1.80$1.6727,840 shs$7.55 million04/16/2024$1.74$1.75+0.57%$1.86$1.747,102 shs$7.49 million04/15/2024$1.86$1.74-6.45%$1.93$1.7312,467 shs$7.45 million04/12/2024$1.87$1.86-0.53%$1.90$1.8024,362 shs$7.96 million04/11/2024$1.88$1.87-0.53%$1.91$1.7841,495 shs$8.00 million04/10/2024$1.87$1.88+0.53%$1.88$1.7312,831 shs$8.05 million04/09/2024$1.89$1.87-1.06%$1.91$1.844,375 shs$8.00 million04/08/2024$1.88$1.89+0.53%$1.90$1.824,980 shs$8.09 million04/05/2024$1.92$1.88-1.83%$1.97$1.8325,001 shs$8.05 million04/04/2024$1.89$1.92+1.32%$1.97$1.8719,927 shs$8.20 million04/03/2024$1.87$1.89+1.07%$2.09$1.8543,525 shs$8.09 million04/02/2024$1.83$1.87+2.19%$1.87$1.828,318 shs$8.00 million04/01/2024$1.81$1.83+1.39%$1.85$1.7715,040 shs$7.83 million03/29/2024$1.81$1.81$1.85$1.7641,388 shs$7.73 million03/28/2024$1.85$1.81-2.43%$1.85$1.7641,388 shs$7.73 million03/27/2024$1.86$1.85-0.54%$1.87$1.7816,601 shs$7.92 million03/26/2024$1.92$1.86-3.12%$1.97$1.8024,274 shs$7.95 million03/25/2024$1.87$1.92+2.67%$1.96$1.8232,008 shs$8.22 million03/22/2024$1.82$1.87+2.75%$1.88$1.835,021 shs$8.00 million03/21/2024$1.86$1.82-2.15%$1.91$1.8214,311 shs$7.79 million03/20/2024$1.85$1.86+0.54%$1.87$1.7912,882 shs$7.96 million03/19/2024$1.72$1.85+7.56%$1.89$1.7165,111 shs$7.92 million03/18/2024$1.73$1.72-0.58%$1.76$1.6723,477 shs$7.36 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.03/15/2024$1.64$1.73+5.49%$1.83$1.6356,193 shs$7.40 million03/14/2024$1.77$1.64-7.34%$1.85$1.6345,816 shs$7.02 million03/13/2024$1.79$1.77-0.84%$1.84$1.7610,508 shs$7.58 million03/12/2024$1.63$1.79+9.51%$1.88$1.6244,339 shs$7.63 million03/11/2024$1.69$1.63-3.55%$1.75$1.6043,228 shs$6.98 million03/08/2024$1.73$1.69-2.31%$1.76$1.6725,063 shs$7.23 million03/07/2024$1.94$1.73-10.59%$1.95$1.63177,175 shs$7.83 million03/06/2024$2.18$1.94-11.24%$2.26$1.9271,136 shs$8.75 million03/05/2024$2.13$2.18+2.35%$2.25$2.0455,347 shs$9.85 million03/04/2024$1.99$2.13+7.04%$2.18$1.9979,080 shs$9.63 million03/01/2024$1.94$1.99+2.58%$2.01$1.9317,672 shs$9.00 million02/29/2024$1.93$1.94+0.52%$2.02$1.9012,740 shs$8.77 million02/28/2024$1.94$1.93-0.52%$2.03$1.9210,298 shs$8.72 million02/27/2024$1.87$1.94+3.74%$1.99$1.8335,494 shs$8.78 million02/26/2024$1.88$1.87-0.53%$1.91$1.8212,565 shs$8.45 million02/23/2024$1.93$1.88-2.59%$1.97$1.8536,318 shs$8.50 million02/22/2024$2.03$1.93-4.93%$2.01$1.9135,946 shs$8.73 million02/21/2024$2.01$2.03+1.00%$2.11$1.9625,680 shs$9.18 million02/20/2024$2.00$2.01+0.50%$2.05$1.9114,467 shs$9.09 million02/19/2024$2.00$2.00$2.04$1.975,000 shs$9.04 million02/16/2024$1.99$2.00+0.50%$2.04$1.975,025 shs$9.04 million02/15/2024$1.94$1.99+2.58%$1.99$1.9420,057 shs$9.00 million02/14/2024$1.87$1.94+3.74%$1.95$1.8611,994 shs$8.77 million02/13/2024$1.95$1.87-4.10%$1.95$1.8523,590 shs$8.45 million02/12/2024$1.97$1.95-1.02%$2.05$1.9525,382 shs$8.82 million Related Companies: NeuroMetrix Stock Chart ProSomnus Stock Chart Vapotherm Stock Chart Vivos Therapeutics Stock Chart Intelligent Bio Solutions Stock Chart Biotricity Stock Chart PetVivo Stock Chart Avinger Stock Chart Titan Medical Stock Chart Microbot Medical Stock Chart Receive PSTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PSTV) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.